
How GLP-1 drugs are supercharging the age of precision nutrition
Could the era of precision nutrition turn the pharma-driven metabolism revolution into a food-based one?

Could the era of precision nutrition turn the pharma-driven metabolism revolution into a food-based one?
Prepared-food sales are climbing, and younger shoppers are leading the push for fresher, clean-label offerings

As GLP-1 drugs disrupt the weight loss market, food and beverage players are racing to unlock the appetite-regulating power of functional ingredients

Producers are proving that good food can do good, too – turning patisserie counters pink, tackling loneliness and funding second chances through every bite

As usage of weight loss medications surges and new therapies emerge, food businesses face a once-in-a-generation opportunity – or risk being left behind